A recent review on PIK3CA‐mutated meningiomas underscores that a subset of these tumors, particularly those with non‐NF2 mutations, exhibit estrogen and progesterone receptor positivity and respond aberrantly to hormonal exposure via PIK3CA pathway activation [59]. The gene discussed is PIK3CA; the disease is meningioma.